MIAMI, FL / ACCESSWIRE / March 21, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. COOL, ONTY, REXX, and KTOV have been added to our watch list today. Continue reading to find out why. - To daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
Majesco Entertainment Co. (COOL) has seen an increase in volume during Monday (3/21) morning's trading session. In its most recent press release, the company announced its Financial Results for the Quarter ending January 31, 2016. Highlights included an update to insider ownership, which stands at 40% (as of the March 16th PR), up from 6% in the comparable prior year period. Also, cash and cash equivalents of $6.65 million as of January 31, 2016. Since Friday (3/18) the company's stock price increased by as much as 18.9% before 10:30AM EST.
Get The Full Report On COOL & Stay Up to Date On All Of This Gaming Company's Progress, Get Them Here.
Oncothyreon Inc (ONTY) is a clinical-stage biopharmaceutical company specializing in the development of innovative therapeutic products for the treatment of cancer. In a recent press release regarding the company's full year and fourth quarter report for 2015, Christopher S. Henney, Chairman and interim CEO of Oncothyreon said, "2015 was a significant year for Oncothyreon, with the company reporting encouraging data from two combination trials of ONT-380 demonstrating that this product candidate may be impactful on HER2-positive breast cancer patients, including those with brain metastases - a patient population in desperate need of new treatment options,"
Members of record by 4PM March 21 will secure a place holder to receive our next report. Get Your Free Membership Now.
Rex Energy Corporation (REXX)reported a fourth quarter loss in the company's most recent earnings release. Rex reported a loss of $98 million and had a loss of $1.85 per share. Revenue came in at $34.5 million during the period, which fell short of Street forecasts. Rex Energy is an independent oil and gas exploration and production company operating in the Appalachian and Illinois Basins within the United States. The company's strategy is to pursue its higher potential exploration drilling prospects while acquiring oil and natural gas properties complementary to its portfolio. On Monday (3/21) the stock increased in price by as much as 9% and recovered slightly from Friday (3/18) afternoon's pull-back.
Enjoy picks like this? Get These Alerts and More on NASDAQ Companies before They Rally, Text the word "NASDAQ" to 77948.
Kitov Pharmaceuticals Holdings LTD (KTOV) has increased significantly in price over the last week. From a low of $2.99 last Monday (3/14) to a high on Monday, 3/21 of $5.06, the stock has moved up 69%. The last announcement was that analyst coverage had been initiated by Rodman and Renshaw, which gave the stock a Buy rating. Kitov Pharmaceuticals is a pharmaceutical company focused on the development of therapeutic candidates for the simultaneous treatment of various clinical conditions. Kitov's lead drug, KIT-302, is formulated for the simultaneous treatment of two clinical conditions - pain caused by osteoarthritis (OA) and high blood pressure, which can be pre-existing or caused by the treatment for OA.
Stay Informed and Up To Date On The Hottest NASDAQ and NYSE Plays. Get Them Here.
About TopNasdaqStocks.com
Looking for stock market and business news headlines? How about up to the minute information on mutual funds and ETFs? Don't forget about the top stock picks of 2016. TopNasdaqStocks.com has it all. Make sure to subscribe to our free newsletter and to receive free text message alerts on your phone, text "NASDAQ" to 77948.
Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor's or other person's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. Top Nasdaq Stocks has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words "anticipate," "intend," "estimate," "believe," "expect," "plans," "should," "potential," "forecast," and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company's actual results could differ materially from those described in any forward-looking statements contained herein. Top Nasdaq Stocks is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit http://topnasdaqstocks.com/index.php/disclaimer/ website for a more detailed discussion of risks and disclosures.
Contact:
Top Nasdaq Stocks
news@topnasdaqstocks.com
SOURCE: Top Nasdaq Stocks
